biolegis
Biolegis is a pan-European network of 22 independent law firms across 20 countries providing coordinated, life sciences-specialized legal services to pharmaceutical, biotech, medical device, and healthcare investor clients.
- Company typePrivate
- Founded-
- Headquarters—
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What biolegis does
Biolegis is a pan-European network of independent law firms providing specialized legal services to life sciences companies and investors across 20 countries. Its member firms — including HAVEL & PARTNERS (Czech Republic/Slovakia), Clyde & Co. (United Kingdom), Advokatfirman Delphi (Sweden), Wardyński & Partners (Poland), and 18 other locally leading practices — deliver coordinated cross-border advice in pharmaceutical regulation, healthcare law, biotech intellectual property, medical devices, product liability, competition law, and life sciences M&A. The network operates as a federation: each firm retains its independence and client relationships, while Biolegis provides a single point of contact for multi-jurisdictional mandates and runs a content and webinar program on EU life sciences regulatory developments.
The underlying service offering is professional legal advice delivered by human practitioners; Biolegis does not operate a software product, technology platform, or proprietary AI tooling. Core competencies are concentrated in member-firm expertise, with disclosed engagements spanning long-term daily advisory for a global Swiss medicinal products and medical devices manufacturer, M&A support for Centene (divestment of Ribera Salud Grupo to Vialto Partners) and Fresenius (acquisition of an ambulance center in Brno and INNEF a.s.), and restructuring advice for Immunoflow. Marketing is executed through the Biolegis website (articles and case studies), webinars on specialized regulatory topics, and professional networks.
Biolegis generates revenue indirectly through member firms' professional-services fees, billed under standard law firm models (hourly rates, fixed fees, success fees) on a case-by-case basis. The company itself is private, has no parent, no subsidiaries, no disclosed funding rounds, and no publicly stated revenue. Aggregate network headcount falls in the 1,001-5,000 range per firmographic data, anchored by HAVEL & PARTNERS' 750+ professionals and supplemented by sizable headcount at Clyde & Co., Advokatfirman Delphi (200 staff/150 lawyers), and Wardyński & Partners (150+ lawyers).
biolegis firmographics
Firmographics- Name
- biolegis
- Legal name
- Biolegis
- Website
- https://biolegis.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Biolegis is a pan-European network of 22 independent law firms across 20 countries providing coordinated, life sciences-specialized legal services to pharmaceutical, biotech, medical device, and healthcare investor clients.
- Ownership category
- akta.pro rank
biolegis industry classification
Industry- Product category
- Legal Services
- NAICS
- Offices of Lawyers (541110), Offices of Lawyers (54111)
- SIC
- Services-Legal Services (8111)
- akta.pro primary industry
- Public Health Law, Legal Counsel & Regulatory Affairs Offices (HLAJACAJ)
- akta.pro secondary industries
- Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
Keywords
biolegis business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Legal Services Fees: Member law firms generate revenue through professional legal services fees charged to life sciences companies and investors across 20 European countries.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
biolegis product offering
Product offeringCore offering
Biolegis is a pan-European network of independent law firms providing specialized legal services to life sciences companies and investors across 20 countries. Member firms deliver advisory and representation across pharmaceutical regulation, healthcare law, biotech intellectual property, M&A transactions, product liability, competition law, and clinical trials. The network provides clients a single coordination point for cross-border matters while each member firm operates independently in its jurisdiction.
Product overview
Biolegis is a pan-European network of independent law firms providing legal services to life sciences companies and investors across 20 countries. The network does not offer software products or technology platforms; rather, it offers legal expertise through member firms specializing in life sciences, pharmaceutical, and healthcare law. Services include regulatory compliance, mergers and acquisitions, intellectual property, competition law, and product liability advisory across jurisdictions including France, Switzerland, Austria, Ireland, Slovakia, Hungary, Turkey, Spain, Norway, Portugal, Sweden, United Kingdom, Czech Republic, Poland, Italy, Netherlands, Israel, Germany, Denmark, Ukraine, and Belgium.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Regulatory Law
- Life Sciences M&A and Corporate Transactions
- Biotech Intellectual Property and Licensing
- Healthcare Law and Corporate Structuring
- Commercial, Tax, and Product Liability Advisory
Companies that use biolegis
Customer profileNamed customers8 records
Segments2 records
Ideal customer profiles2 records
biolegis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
biolegis partnerships and signals
Strategic signalPartnerships
21 partnerships are on record, tiered member firm.
- Harlay Avocatsmember firmFrench member firm in the Biolegis network providing life sciences legal expertise
- Walder Wyss Ltd.member firmSwiss member firm in the Biolegis network
- Dorda Brugger Jordismember firmAustrian member firm in the Biolegis network
- Mason Hayes & Curranmember firmIrish member firm in the Biolegis network
- HAVEL & PARTNERSmember firmCzech and Slovak member firm, largest independent law firm in Central Europe, with specialized life sciences practice
- Szecskay Attorneys at Lawmember firmHungarian member firm in the Biolegis network
- GUN Partnersmember firmTurkish member firm in the Biolegis network
- Lenermember firmSpanish member firm in the Biolegis network
- Simonsen Vogt Wiigmember firmNorwegian member firm in the Biolegis network
- Coelho Ribeiro & Associadosmember firmPortuguese member firm in the Biolegis network
- Advokatfirman Delphimember firmSwedish member firm with extensive life sciences practice, offices in Stockholm, Gothenburg, Malmö and Linköping
- Clyde & Co. LLPmember firmUK member firm with offices in London, Dubai, Mumbai and Shanghai, serving life sciences clients globally
- Wardyński & Partnersmember firmPolish member firm since 1988, with offices in Warsaw, Poznań, Wrocław and Kraków
- Portolano Cavallomember firmItalian member firm in the Biolegis network
- Kennedy Van der Laanmember firmDutch member firm in the Biolegis network
- Gornitzky & Co.member firmIsraeli member firm in the Biolegis network
- SKW Schwarzmember firmGerman member firm in the Biolegis network
- Gorrissen Federspielmember firmDanish member firm in the Biolegis network
- Astersmember firmUkrainian member firm in the Biolegis network
- Altiusmember firmBelgian member firm in the Biolegis network
- Attorneys at Law Borenius Ltd.member firmFinnish member firm in the Biolegis network
Scale indicators3 records
Recent moves4 records
Expansion highlights4 records
biolegis competitors and assessment
Company assessmentOthers
- Meritas: Meritas is an international legal network of independent law firms across 90+ jurisdictions. Comparable network structure to Biolegis, though generalist; illustrates how federated legal networks compete for cross-border mandates.
- Lex Mundi: Lex Mundi is a global network of independent law firms providing cross-jurisdictional services. Network-level peer: Biolegis operates the same federated model but vertical-focused on life sciences, while Lex Mundi is generalist. Useful proxy for network economics and competitive dynamics.
Broad incumbents
- Latham & Watkins: Latham & Watkins handles premier life sciences M&A, capital markets, and licensing work globally. Competes for the same high-end life sciences matters but as part of a full-service global firm — overlapping capability but broader portfolio than Biolegis's vertical focus.
- Sidley Austin: Sidley Austin has a top-tier Life Sciences practice covering regulatory, IP, and transactional work for global pharma and biotech clients. Comparable in serving the same buyer segment but operates as an integrated global firm rather than a European-federated network.
- Hogan Lovells: Hogan Lovells has a globally recognized Life Sciences & Health Care practice spanning regulatory, IP, and transactional work across the US, UK, and Europe. A broad incumbent with overlapping life sciences capability, but as part of a full-service global portfolio rather than a dedicated life sciences network.
Direct peers
- Bird & Bird: Bird & Bird is widely regarded as the leading European law firm for life sciences and healthcare with deep regulatory, IP, and commercial practices across the UK and Continental Europe. Directly comparable to Biolegis in vertical specialization, though structured as an integrated firm rather than a federation.
- Arnold & Porter: Arnold & Porter operates a leading Life Sciences & Healthcare Regulatory practice with deep FDA/EMA expertise and a strong European footprint. Directly competes for sophisticated pharma/biotech regulatory mandates and M&A work that Biolegis member firms target.
- McDermott Will & Emery: McDermott Will & Emery has a strongly rated Life Sciences practice with European offices in Germany and the UK. Compares to Biolegis in focusing on regulated pharma/medtech clients and cross-border EU matters.
Emerging players
- Cooley LLP: Cooley has built a top-tier life sciences practice focused on biotech, IPOs, and licensing deals across the US and Europe. Strong overlap with Biolegis in biotech client base but US-anchored and integrated rather than European-federated.
- Reed Smith: Reed Smith has an active Life Sciences group spanning the UK and Europe. Comparable mid-sized competitor for European pharma/biotech regulatory and commercial mandates; smaller life sciences bench than Bird & Bird or Hogan Lovells.
Market position
Strengths1 record
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
biolegis social profiles
Digital presencebiolegis financial estimates
Financial estimateRevenue estimate
Valuation estimate
biolegis leadership team
Management profileNumber of profiles
biolegis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
biolegis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about biolegis
What does biolegis do?
Biolegis is a pan-European network of independent law firms providing specialized legal services to life sciences companies and investors across 20 countries. Member firms deliver advisory and representation across pharmaceutical regulation, healthcare law, biotech intellectual property, M&A transactions, product liability, competition law, and clinical trials. The network provides clients a single coordination point for cross-border matters while each member firm operates independently in its jurisdiction.
Is biolegis a public or private company?
biolegis is a private company. It is classified as unknown and is currently operating.
When was biolegis founded?
biolegis was founded in -1. It employs 1,001 to 5,000 people.
How does biolegis make money?
One revenue line is on record: legal Services Fees.
Who are biolegis's main competitors?
Others on record are Meritas and Lex Mundi. Broad incumbents are Latham & Watkins, Sidley Austin and Hogan Lovells. Direct peers are Bird & Bird, Arnold & Porter and McDermott Will & Emery. Emerging players are Cooley LLP and Reed Smith.
Does biolegis have an API?
No public API is recorded for biolegis.
What industry is biolegis in?
biolegis's product category is Legal Services. Its primary akta.pro industry code is HLAJACAJ, Public Health Law, Legal Counsel & Regulatory Affairs Offices, with a secondary code of HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA). Its NAICS code is 541110 and its SIC code is 8111.